Sangamo Therapeutics Inc. logo

Sangamo Therapeutics Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

6.33
 
USD
  
0.51
  
(8.76%)
Optionable: Yes  Market Cap: 820 M  90-day average vol: 1,765,205

Previous close: 5.82  Open: 5.85  Bid: 6.28  Ask: 6.28
52 week range    
3.12   
   11.49
Peers   
ALNY / 
GILD / 
AMGN / 
BIIB / 
BMRN / 
JNJ / 
DOW / 
Last updated: Sunday 14th August 2022
53
MarketXLS Rank marketxls
60
Value marketxls
69
Technical marketxls
31
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ALNY

17 B-19.3148.65

AMGN

0.0347129 B23.4223.53

BIIB

34 B21.6221.3

BMRN

16 B886.389.37

DOW

0.046245 B7.159.91

GILD

0.044486 B11.763.76

JNJ

0.0247450 B22.1171.06

MRK

0.0356207 B28.877.58
Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 47.848


Financials

SGMO Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues22 M24 M46 M40 M19 M37 M84 M102 M118 M111 M
Cost of sales-2 M-1 M-2 M-2 M-1 M-8250003 M-5 M-13 M-20 M
Gross operating profit22 M24 M46 M40 M19 M37 M84 M102 M118 M111 M
Selling Gen & administrative expense12 M14 M16 M19 M26 M27 M47 M62 M67 M63 M
Research & development expense32 M37 M57 M67 M66 M66 M115 M146 M181 M231 M
Operating income-22 M-27 M-27 M-47 M-73 M-56 M-77 M-105 M-130 M-183 M
floaterest income0000000000
floaterest expense0000000000
Other income net-660008200036400043100088700000000
Pre-tax Income (EBT)-22 M-27 M-26 M-46 M-72 M-55 M-69 M-95 M-121 M-178 M
Income taxes000-6 M-14000000345000306000
Net income from total operations-22 M-27 M-26 M-41 M-72 M-55 M-69 M-95 M-121 M-178 M
Minority floaterest0000000000
Total net income-22 M-27 M-26 M-41 M-72 M-55 M-68 M-95 M-121 M-178 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-22 M-27 M-26 M-41 M-72 M-55 M-69 M-95 M-121 M-178 M
Depreciation2 M1 M2 M2 M1 M825000-3 M5 M13 M20 M
Amortization0000000000
Operating income before depreciation (EBITDA)-22 M-26 M-26 M-46 M-72 M-55 M-75 M-96 M-116 M-166 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-0.42-0.48-0.39-0.58-1.02-0.7-0.7-0.85-0.9-1.23
Diluted EPS total-0.42-0.48-0.39-0.58-1.02-0.7-0.7-0.85-0.9-1.23
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!